'Use ARBs to treat hypertensives with CKD'

Hypertensive patients with chronic kidney disease (CKD) may be best treated with an angiotensin receptor blocker (ARB), suggests Japanese research.

The findings come from sub-analysis of a study into the benefits of ARBs in patients with coronary artery disease (CAD).

This showed that the risk of major adverse cardiac events was reduced by 21 per cent in patients with impaired renal function.

ARBs also reduced the risk of new-onset diabetes by 63 per cent, delegates were told at the American Heart Association scientific sessions in Orlando, Florida.

For the study, over 2,000 patients with CAD were randomly assigned to treatment with the ARB candesartan or standard therapy.

In Japan this is a calcium-channel blocker or beta-blocker, followed by a diuretic. However, 71 per cent of these patients were also taking ACE inhibitor, said lead researcher Dr Hiroshi Kasanuki from Tokyo Women’s Medical University.

 The study showed that ARBs had little effect on the risk of major adverse cardiac events in these patients at four-year follow-up, reducing risk by a non-significant 11 per cent.

rachel.liddle@haymarket.com

For more details visit the Scientific Sessions 2007 website  

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Practices handed one-month opt-out window as revamped network DES unveiled

Practices handed one-month opt-out window as revamped network DES unveiled

NHS England has unveiled a revamped DES package for 2020/21 confirming new targets,...

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered a huge increase in face-to-face appointments in the week before NHS...

RCGP facing legal action over stance on assisted dying

RCGP facing legal action over stance on assisted dying

The RCGP is facing legal action over its decision to remain opposed to assisted dying...

Medeconomics Live aims to help practices thrive under the new GP contract

Medeconomics Live aims to help practices thrive under the new GP contract

The one-day, virtual Medeconomics Live conference aims to provide practices with...

GPs face wave of abuse and complaints after NHS England face-to-face appointments claims

GPs face wave of abuse and complaints after NHS England face-to-face appointments claims

GP practices have faced a wave of abuse and complaints after a letter from NHS England...

Government denies plan to make GPs 'gatekeepers' of COVID-19 testing

Government denies plan to make GPs 'gatekeepers' of COVID-19 testing

The government has denied plans to make GPs 'gatekeepers' of the struggling COVID-19...